In an interview with SFC, Dr. Severin Schwan, Chairman of the Board of Directors at the Roche Group, shared his views on optimizing the pharmaceutical innovation ecosystem and meeting unmet healthcare demands as China is promoting high-quality development.
Schwan emphasized, "I've witnessed firsthand the incredible innovation and untapped potential in this region. We don't merely view China as a pivotal market but are dedicated to fostering it as an innovation epicenter through open collaboration, ultimately delivering improved healthcare solutions to patients in China and globally."
Related News
